>
Qilian International Holding logo

QLI - Qilian International Holding Share Price

$4.33 -0.0  -1.0%

Last Trade - 2:34pm

Sector
Healthcare
Size
Small Cap
Market Cap £113.6m
Enterprise Value £112.3m
Revenue £36.4m
Position in Universe 4765th / 6848
Bullish
Bearish
Unlock QLI Revenue
Momentum
Relative Strength (%)
1m -15.6%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -80.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Sep 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 22.5 50.4 46.1 50.0 +30.5%
+265.4 +3.1 -5.0
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 30 September 2020, QilianInternational Holding Group Ltd revenues increased 9% to$50M. Net income decreased 5% to $5.1M. Revenues reflectOxytetracycline & Licorice products and TCMD segmentincrease of 8% to $32.6M, Heparin products and Sausagecasing segment increase of 9% to $16.7M. Net income wasoffset by Interest Expense increase of 9% to $243K(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

QLI Revenue Unlock QLI Revenue

Net Income

QLI Net Income Unlock QLI Revenue

Normalised EPS

QLI Normalised EPS Unlock QLI Revenue

PE Ratio Range

QLI PE Ratio Range Unlock QLI Revenue

Dividend Yield Range

QLI Dividend Yield Range Unlock QLI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
QLI EPS Forecasts Unlock QLI Revenue
Profile Summary

Qilian International Holding Group Ltd is a China-based company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. Its main brand is Qilian Shan. The Company principally operates its businesses within the domestic market.

Directors
Last Annual September 30th, 2020
Last Interim September 30th, 2020
Incorporated February 7, 2019
Public Since January 12, 2021
No. of Shareholders: n/a
No. of Employees: 292
Sector Healthcare
Industry Pharmaceuticals
Index Nasdaq Composite ,
Exchange NASDAQ Global Market
Shares in Issue 35,750,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
QLI Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for QLI
Upcoming Events for QLI
Frequently Asked Questions for Qilian International Holding
What is the Qilian International Holding share price?

As of 2:34pm, shares in Qilian International Holding are trading at $4.33, giving the company a market capitalisation of £113.6m. This share price information is delayed by 15 minutes.

How has the Qilian International Holding share price performed this year?

Shares in Qilian International Holding are currently trading at $4.33 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Qilian International Holding price has moved by % over the past year.

What are the analyst and broker recommendations for Qilian International Holding?

There are no analysts currently covering Qilian International Holding.

When will Qilian International Holding next release its financial results?

Qilian International Holding is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Qilian International Holding dividend yield?

Qilian International Holding does not currently pay a dividend.

Does Qilian International Holding pay a dividend?

Qilian International Holding does not currently pay a dividend.

When does Qilian International Holding next pay dividends?

Qilian International Holding does not currently pay a dividend.

How do I buy Qilian International Holding shares?

To buy shares in Qilian International Holding you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Qilian International Holding?

Shares in Qilian International Holding are currently trading at $4.33, giving the company a market capitalisation of £113.6m.

Where are Qilian International Holding shares listed? Where are Qilian International Holding shares listed?

Here are the trading details for Qilian International Holding:

Country of listing: United States
Exchange: NMQ
Ticker Symbol: QLI
What kind of share is Qilian International Holding?

Based on an overall assessment of its quality, value and momentum, Qilian International Holding is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Qilian International Holding share price forecast 2021?

We were not able to load any forecast data for Qilian International Holding.

How can I tell whether the Qilian International Holding share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Qilian International Holding. Over the past six months, the relative strength of its shares against the market has been %. At the current price of $4.33, shares in Qilian International Holding are trading at -29.82% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Qilian International Holding PE Ratio?

The Qilian International Holding PE ratio based on its reported earnings over the past 12 months is 30.2. The shares are currently trading at $4.33.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Qilian International Holding?

Qilian International Holding's management team is headed by:

Zhanchang Xin - CHM
Haiping Shi - DRC
Lina Lu - IND
Ming Jing - IND
Li Han - IND
Who are the major shareholders of Qilian International Holding?

Here are the top five shareholders of Qilian International Holding based on the size of their shareholding:

Xin (Zhanchang) Individual Investor
Percentage owned: 33.57% (12.0m shares)
Zhijiu Holdings Ltd Corporation
Percentage owned: 19.95% (7.13m shares)
Gandikang Holdings Ltd Corporation
Percentage owned: 18.79% (6.72m shares)
Ahanzhai Development Co., Ltd Corporation
Percentage owned: 5.14% (1.84m shares)
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund
Percentage owned: 0.07% (23.6k shares)
Similar to QLI
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.